Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesareā¦ (NCT06493968) | Clinical Trial Compass
RecruitingNot Applicable
Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy
Egypt70 participantsStarted 2024-07-01
Plain-language summary
Objectives: To evaluate the effect of oxytocin in reducing intraoperative blood loss in patients with PAS disorders planned for cesarean hysterectomy.
Who can participate
Age range20 Years ā 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pregnancy of singleton living fetus
* Previous one or more cesarean sections
* Gestational age: \> 32 weeks
* The following ultrasound markers such as "loss of clear retroplacental translucency", "myometrial thinning", "abnormal lacunae", "irregular bladder wall", "utero-vesicalhypervascularity".
* Preoperative hemoglobin more than 10 gm/dl
* Cases with PAS that will undergoing CS Hysterectomy
Exclusion Criteria:
* Maternal medical disorders e.g.: coagulation defects, cardiac diseases etc.ā¦.
* Any known or reported hypersensitivity to the used medication.
* All cases with spontaneous placental separation at laparotomy.
* All patients undergoing conservative management of PAS.
* All cases which necessitate emergency termination.